Literature DB >> 8938579

The "muscle hypothesis" of chronic heart failure.

A J Coats1.   

Abstract

Chronic heart failure is a well-recognized syndrome in which left ventricular impairment produces a constellation of secondary changes in other organ symptoms leading to symptoms such as muscular fatigue and dyspnoea and objective limitation to exercise tolerance. With modern drug therapy of diuretics and ACE inhibitors, the majority of patients have minimal if any signs of congestion, and yet severe symptomatic limitation remains. This limitation bears little relationship to conventional measures of either left ventricular function or the haemodynamic profile of the patient. The symptoms limiting exercise are predominantly fatigue or dyspnoea, and yet the classical pathophysiological explanations for their genesis now seem inadequate. Recent investigations, as demonstrated, in part, by the research presented in this symposium, attest to the importance of abnormalities in peripheral blood flow and in skeletal muscle in producing both objective limitation to exercise and in explaining the generation of the exercise-limiting symptoms of the syndrome of stable optimally treated chronic heart failure. In addition it is now evident that these muscle changes may in addition have pathophysiological significance for the maintenance of sympatho-excitation during exercise and potentially therefore in the progression of left ventricular remodelling and in the susceptibility to ventricular arrhythmias. This paper presents some of the background evidence which leads to the hypothesis that a feedback loop links changes in skeletal muscle to abnormal reflex cardiopulmonary control which may both limit exercise and be harmful in the progression of the syndrome.

Entities:  

Mesh:

Year:  1996        PMID: 8938579     DOI: 10.1006/jmcc.1996.0218

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  43 in total

1.  Case report: exercise in a patient with acute decompensated heart failure receiving positive inotropic therapy.

Authors:  Ricard Paul E H; Robert Camarda; Laura Little Foley; Michael M Givertz; Lawrence P Cahalin
Journal:  Cardiopulm Phys Ther J       Date:  2011-06

2.  Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure.

Authors:  Rebecca S Boxer; Anne M Kenny; Vinay K Cheruvu; Marianne Vest; Justin J Fiutem; Ileana I Piña
Journal:  Am Heart J       Date:  2010-11       Impact factor: 4.749

Review 3.  Clinical safety of blood flow-restricted training? A comprehensive review of altered muscle metaboreflex in cardiovascular disease during ischemic exercise.

Authors:  Michelle Cristina-Oliveira; Kamila Meireles; Marty D Spranger; Donal S O'Leary; Hamilton Roschel; Tiago Peçanha
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-11-08       Impact factor: 4.733

Review 4.  Inspiratory muscle training in heart disease and heart failure: a review of the literature with a focus on method of training and outcomes.

Authors:  Lawrence P Cahalin; Ross Arena; Marco Guazzi; Jonathan Myers; Gerson Cipriano; Gaspar Chiappa; Carl J Lavie; Daniel E Forman
Journal:  Expert Rev Cardiovasc Ther       Date:  2013-02

5.  Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification.

Authors:  L C Davies; D P Francis; M Piepoli; A C Scott; P Ponikowski; A J Coats
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

Review 6.  Gene-environment interactions and the response to exercise.

Authors:  H Montgomery; D Brull
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

7.  Improved Ventilatory Efficiency with Locomotor Muscle Afferent Inhibition is Strongly Associated with Leg Composition in Heart Failure.

Authors:  Manda L Keller-Ross; Bruce D Johnson; Rickey E Carter; Michael J Joyner; John H Eisenach; Timothy B Curry; Thomas P Olson
Journal:  Int J Cardiol       Date:  2015-08-29       Impact factor: 4.164

8.  A randomized controlled trial of high dose vitamin D3 in patients with heart failure.

Authors:  Rebecca S Boxer; Anne M Kenny; Brian J Schmotzer; Marianne Vest; Justin J Fiutem; Ileana L Piña
Journal:  JACC Heart Fail       Date:  2013-02       Impact factor: 12.035

Review 9.  Energy metabolism in heart failure.

Authors:  Renée Ventura-Clapier; Anne Garnier; Vladimir Veksler
Journal:  J Physiol       Date:  2003-12-05       Impact factor: 5.182

Review 10.  Prevalence and importance of comorbidities in patients with heart failure.

Authors:  Filippos K Triposkiadis; John Skoularigis
Journal:  Curr Heart Fail Rep       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.